Sakar Healthcare, a company in the Pharmaceuticals industry, reported revenue of ₹87 crore and net profit of ₹11 crore for the September 2026 quarter.
Sakar Healthcare (NSE: SAKAR) closed at ₹1,023.40 on 20 Nov 2026, up 161.4% over the past year. Its market capitalisation is ₹2,277 crore and it trades at 53.1 times earnings.
Incorporated in 2004, Sakar Healthcare Ltd is in the business of manufacturing Research & Development of Pharmaceutical products
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.